IBDEI1BR ; ; 01-FEB-2022
;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
Q:'DIFQR(358.3) F I=1:2 S X=$T(Q+I) Q:X="" S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,999) S:$A(Y)=61 Y=$E(Y,2,999) X NO E S @X=Y
Q Q
;;^UTILITY(U,$J,358.3,21413,1,4,0)
;;=4^N05.0
;;^UTILITY(U,$J,358.3,21413,2)
;;=^5015541
;;^UTILITY(U,$J,358.3,21414,0)
;;=N05.8^^70^917^23
;;^UTILITY(U,$J,358.3,21414,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21414,1,3,0)
;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
;;^UTILITY(U,$J,358.3,21414,1,4,0)
;;=4^N05.8
;;^UTILITY(U,$J,358.3,21414,2)
;;=^5134085
;;^UTILITY(U,$J,358.3,21415,0)
;;=N18.6^^70^917^4
;;^UTILITY(U,$J,358.3,21415,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21415,1,3,0)
;;=3^ESRD
;;^UTILITY(U,$J,358.3,21415,1,4,0)
;;=4^N18.6
;;^UTILITY(U,$J,358.3,21415,2)
;;=^303986
;;^UTILITY(U,$J,358.3,21416,0)
;;=R59.9^^70^918^4
;;^UTILITY(U,$J,358.3,21416,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21416,1,3,0)
;;=3^Enlarged Lymph Nodes,Unspec
;;^UTILITY(U,$J,358.3,21416,1,4,0)
;;=4^R59.9
;;^UTILITY(U,$J,358.3,21416,2)
;;=^5019531
;;^UTILITY(U,$J,358.3,21417,0)
;;=R59.1^^70^918^2
;;^UTILITY(U,$J,358.3,21417,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21417,1,3,0)
;;=3^Enlarged Lymph Nodes,Generalized
;;^UTILITY(U,$J,358.3,21417,1,4,0)
;;=4^R59.1
;;^UTILITY(U,$J,358.3,21417,2)
;;=^5019530
;;^UTILITY(U,$J,358.3,21418,0)
;;=R59.0^^70^918^3
;;^UTILITY(U,$J,358.3,21418,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21418,1,3,0)
;;=3^Enlarged Lymph Nodes,Localized
;;^UTILITY(U,$J,358.3,21418,1,4,0)
;;=4^R59.0
;;^UTILITY(U,$J,358.3,21418,2)
;;=^5019529
;;^UTILITY(U,$J,358.3,21419,0)
;;=D64.9^^70^918^1
;;^UTILITY(U,$J,358.3,21419,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21419,1,3,0)
;;=3^Anemia,Unspec
;;^UTILITY(U,$J,358.3,21419,1,4,0)
;;=4^D64.9
;;^UTILITY(U,$J,358.3,21419,2)
;;=^5002351
;;^UTILITY(U,$J,358.3,21420,0)
;;=R79.9^^70^919^1
;;^UTILITY(U,$J,358.3,21420,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21420,1,3,0)
;;=3^Abnormal Finding of Blood Chemistry,Unspec
;;^UTILITY(U,$J,358.3,21420,1,4,0)
;;=4^R79.9
;;^UTILITY(U,$J,358.3,21420,2)
;;=^5019594
;;^UTILITY(U,$J,358.3,21421,0)
;;=R78.71^^70^919^2
;;^UTILITY(U,$J,358.3,21421,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21421,1,3,0)
;;=3^Abnormal Lead Level in Blood
;;^UTILITY(U,$J,358.3,21421,1,4,0)
;;=4^R78.71
;;^UTILITY(U,$J,358.3,21421,2)
;;=^5019586
;;^UTILITY(U,$J,358.3,21422,0)
;;=R79.0^^70^919^3
;;^UTILITY(U,$J,358.3,21422,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21422,1,3,0)
;;=3^Abnormal Level of Blood Mineral
;;^UTILITY(U,$J,358.3,21422,1,4,0)
;;=4^R79.0
;;^UTILITY(U,$J,358.3,21422,2)
;;=^5019590
;;^UTILITY(U,$J,358.3,21423,0)
;;=R78.79^^70^919^4
;;^UTILITY(U,$J,358.3,21423,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21423,1,3,0)
;;=3^Abnormal Level of Heavy Metals in Blood
;;^UTILITY(U,$J,358.3,21423,1,4,0)
;;=4^R78.79
;;^UTILITY(U,$J,358.3,21423,2)
;;=^5019587
;;^UTILITY(U,$J,358.3,21424,0)
;;=E79.0^^70^919^10
;;^UTILITY(U,$J,358.3,21424,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21424,1,3,0)
;;=3^Hyperuricemia w/o Signs of Inflam Arthrit/Tophaceous Disease
;;^UTILITY(U,$J,358.3,21424,1,4,0)
;;=4^E79.0
;;^UTILITY(U,$J,358.3,21424,2)
;;=^5002978
;;^UTILITY(U,$J,358.3,21425,0)
;;=K74.69^^70^919^5
;;^UTILITY(U,$J,358.3,21425,1,0)
;;=^358.31IA^4^2
;;^UTILITY(U,$J,358.3,21425,1,3,0)
;;=3^Cirrhosis of Liver NEC
;;^UTILITY(U,$J,358.3,21425,1,4,0)
;;=4^K74.69
;;^UTILITY(U,$J,358.3,21425,2)
;;=^5008823
;;^UTILITY(U,$J,358.3,21426,0)
;;=K74.60^^70^919^6
--- Routine Detail --- with STRUCTURED ROUTINE LISTING ---[H[J[2J[HIBDEI1BR 3791 printed Nov 22, 2024@17:15:48 Page 2
IBDEI1BR ; ; 01-FEB-2022
+1 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;FEB 01, 2022
+2 if 'DIFQR(358.3)
QUIT
FOR I=1:2
SET X=$TEXT(Q+I)
if X=""
QUIT
SET Y=$EXTRACT($TEXT(Q+I+1),4,999)
SET X=$EXTRACT(X,4,999)
if $ASCII(Y)=126
SET I=I+1
SET Y=$EXTRACT(Y,2,999)_$EXTRACT($TEXT(Q+I+1),5,999)
if $ASCII(Y)=61
SET Y=$EXTRACT(Y,2,999)
XECUTE NO
IF '$TEST
SET @X=Y
Q QUIT
+1 ;;^UTILITY(U,$J,358.3,21413,1,4,0)
+2 ;;=4^N05.0
+3 ;;^UTILITY(U,$J,358.3,21413,2)
+4 ;;=^5015541
+5 ;;^UTILITY(U,$J,358.3,21414,0)
+6 ;;=N05.8^^70^917^23
+7 ;;^UTILITY(U,$J,358.3,21414,1,0)
+8 ;;=^358.31IA^4^2
+9 ;;^UTILITY(U,$J,358.3,21414,1,3,0)
+10 ;;=3^Nephritic Syndrome w/ Morphologic Changes,Unspec
+11 ;;^UTILITY(U,$J,358.3,21414,1,4,0)
+12 ;;=4^N05.8
+13 ;;^UTILITY(U,$J,358.3,21414,2)
+14 ;;=^5134085
+15 ;;^UTILITY(U,$J,358.3,21415,0)
+16 ;;=N18.6^^70^917^4
+17 ;;^UTILITY(U,$J,358.3,21415,1,0)
+18 ;;=^358.31IA^4^2
+19 ;;^UTILITY(U,$J,358.3,21415,1,3,0)
+20 ;;=3^ESRD
+21 ;;^UTILITY(U,$J,358.3,21415,1,4,0)
+22 ;;=4^N18.6
+23 ;;^UTILITY(U,$J,358.3,21415,2)
+24 ;;=^303986
+25 ;;^UTILITY(U,$J,358.3,21416,0)
+26 ;;=R59.9^^70^918^4
+27 ;;^UTILITY(U,$J,358.3,21416,1,0)
+28 ;;=^358.31IA^4^2
+29 ;;^UTILITY(U,$J,358.3,21416,1,3,0)
+30 ;;=3^Enlarged Lymph Nodes,Unspec
+31 ;;^UTILITY(U,$J,358.3,21416,1,4,0)
+32 ;;=4^R59.9
+33 ;;^UTILITY(U,$J,358.3,21416,2)
+34 ;;=^5019531
+35 ;;^UTILITY(U,$J,358.3,21417,0)
+36 ;;=R59.1^^70^918^2
+37 ;;^UTILITY(U,$J,358.3,21417,1,0)
+38 ;;=^358.31IA^4^2
+39 ;;^UTILITY(U,$J,358.3,21417,1,3,0)
+40 ;;=3^Enlarged Lymph Nodes,Generalized
+41 ;;^UTILITY(U,$J,358.3,21417,1,4,0)
+42 ;;=4^R59.1
+43 ;;^UTILITY(U,$J,358.3,21417,2)
+44 ;;=^5019530
+45 ;;^UTILITY(U,$J,358.3,21418,0)
+46 ;;=R59.0^^70^918^3
+47 ;;^UTILITY(U,$J,358.3,21418,1,0)
+48 ;;=^358.31IA^4^2
+49 ;;^UTILITY(U,$J,358.3,21418,1,3,0)
+50 ;;=3^Enlarged Lymph Nodes,Localized
+51 ;;^UTILITY(U,$J,358.3,21418,1,4,0)
+52 ;;=4^R59.0
+53 ;;^UTILITY(U,$J,358.3,21418,2)
+54 ;;=^5019529
+55 ;;^UTILITY(U,$J,358.3,21419,0)
+56 ;;=D64.9^^70^918^1
+57 ;;^UTILITY(U,$J,358.3,21419,1,0)
+58 ;;=^358.31IA^4^2
+59 ;;^UTILITY(U,$J,358.3,21419,1,3,0)
+60 ;;=3^Anemia,Unspec
+61 ;;^UTILITY(U,$J,358.3,21419,1,4,0)
+62 ;;=4^D64.9
+63 ;;^UTILITY(U,$J,358.3,21419,2)
+64 ;;=^5002351
+65 ;;^UTILITY(U,$J,358.3,21420,0)
+66 ;;=R79.9^^70^919^1
+67 ;;^UTILITY(U,$J,358.3,21420,1,0)
+68 ;;=^358.31IA^4^2
+69 ;;^UTILITY(U,$J,358.3,21420,1,3,0)
+70 ;;=3^Abnormal Finding of Blood Chemistry,Unspec
+71 ;;^UTILITY(U,$J,358.3,21420,1,4,0)
+72 ;;=4^R79.9
+73 ;;^UTILITY(U,$J,358.3,21420,2)
+74 ;;=^5019594
+75 ;;^UTILITY(U,$J,358.3,21421,0)
+76 ;;=R78.71^^70^919^2
+77 ;;^UTILITY(U,$J,358.3,21421,1,0)
+78 ;;=^358.31IA^4^2
+79 ;;^UTILITY(U,$J,358.3,21421,1,3,0)
+80 ;;=3^Abnormal Lead Level in Blood
+81 ;;^UTILITY(U,$J,358.3,21421,1,4,0)
+82 ;;=4^R78.71
+83 ;;^UTILITY(U,$J,358.3,21421,2)
+84 ;;=^5019586
+85 ;;^UTILITY(U,$J,358.3,21422,0)
+86 ;;=R79.0^^70^919^3
+87 ;;^UTILITY(U,$J,358.3,21422,1,0)
+88 ;;=^358.31IA^4^2
+89 ;;^UTILITY(U,$J,358.3,21422,1,3,0)
+90 ;;=3^Abnormal Level of Blood Mineral
+91 ;;^UTILITY(U,$J,358.3,21422,1,4,0)
+92 ;;=4^R79.0
+93 ;;^UTILITY(U,$J,358.3,21422,2)
+94 ;;=^5019590
+95 ;;^UTILITY(U,$J,358.3,21423,0)
+96 ;;=R78.79^^70^919^4
+97 ;;^UTILITY(U,$J,358.3,21423,1,0)
+98 ;;=^358.31IA^4^2
+99 ;;^UTILITY(U,$J,358.3,21423,1,3,0)
+100 ;;=3^Abnormal Level of Heavy Metals in Blood
+101 ;;^UTILITY(U,$J,358.3,21423,1,4,0)
+102 ;;=4^R78.79
+103 ;;^UTILITY(U,$J,358.3,21423,2)
+104 ;;=^5019587
+105 ;;^UTILITY(U,$J,358.3,21424,0)
+106 ;;=E79.0^^70^919^10
+107 ;;^UTILITY(U,$J,358.3,21424,1,0)
+108 ;;=^358.31IA^4^2
+109 ;;^UTILITY(U,$J,358.3,21424,1,3,0)
+110 ;;=3^Hyperuricemia w/o Signs of Inflam Arthrit/Tophaceous Disease
+111 ;;^UTILITY(U,$J,358.3,21424,1,4,0)
+112 ;;=4^E79.0
+113 ;;^UTILITY(U,$J,358.3,21424,2)
+114 ;;=^5002978
+115 ;;^UTILITY(U,$J,358.3,21425,0)
+116 ;;=K74.69^^70^919^5
+117 ;;^UTILITY(U,$J,358.3,21425,1,0)
+118 ;;=^358.31IA^4^2
+119 ;;^UTILITY(U,$J,358.3,21425,1,3,0)
+120 ;;=3^Cirrhosis of Liver NEC
+121 ;;^UTILITY(U,$J,358.3,21425,1,4,0)
+122 ;;=4^K74.69
+123 ;;^UTILITY(U,$J,358.3,21425,2)
+124 ;;=^5008823
+125 ;;^UTILITY(U,$J,358.3,21426,0)
+126 ;;=K74.60^^70^919^6
